Dorsey & Whitney Trust CO LLC grew its stake in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB – Get Rating) by 22.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 164,000 shares of the company’s stock after buying an additional 30,000 shares during the quarter. Dorsey & Whitney Trust CO LLC owned 0.23% of AquaBounty Technologies worth $280,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Cantor Fitzgerald L. P. purchased a new stake in shares of AquaBounty Technologies during the first quarter worth about $25,000. Bank of New York Mellon Corp boosted its holdings in shares of AquaBounty Technologies by 9.0% during the first quarter. Bank of New York Mellon Corp now owns 179,930 shares of the company’s stock worth $337,000 after purchasing an additional 14,882 shares during the period. Commonwealth Equity Services LLC boosted its holdings in shares of AquaBounty Technologies by 72.4% during the second quarter. Commonwealth Equity Services LLC now owns 35,513 shares of the company’s stock worth $60,000 after purchasing an additional 14,916 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of AquaBounty Technologies by 11.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 147,231 shares of the company’s stock worth $276,000 after purchasing an additional 14,966 shares during the period. Finally, Cetera Investment Advisers purchased a new stake in shares of AquaBounty Technologies during the second quarter worth about $30,000. 34.85% of the stock is owned by institutional investors.
AquaBounty Technologies Price Performance
AquaBounty Technologies stock opened at $0.69 on Thursday. The company has a current ratio of 7.81, a quick ratio of 7.68 and a debt-to-equity ratio of 0.04. The firm has a 50-day moving average of $0.72 and a 200-day moving average of $1.19. AquaBounty Technologies, Inc. has a 1-year low of $0.58 and a 1-year high of $2.80.
AquaBounty Technologies Company Profile
AquaBounty Technologies, Inc, a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.
- Get a free copy of the StockNews.com research report on AquaBounty Technologies (AQB)
- Institutional Support for Analog Devices Remains High
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.